|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Intrauterine contraceptive devices and risk of pelvic inflammatory disease: |
| standard of care in high STI prevalence settings. |
| Reproductive Health Matters. 2004 May;12(23):136-143. |
| The intrauterine contraceptive device (IUD) is highly effective and cost-effective. IUD use is limited in some regions, |
| however, due to concerns about increased risk of pelvic inflammatory disease (PID) and subsequent complications |
| such as infertility and ectopic pregnancy. Recent reviews suggest that the overall risk of PID with modern IUDs is |
| lower than previously thought, at least in regions with a low prevalence of sexually transmitted infections (STIs). Risk |
| of PID may be higher, however, in places where gonorrhoea and chlamydia are prevalent, where screening for STIs is |
| limited and where aseptic conditions for insertion are difficult to ensure. A World Health Organization multi-centre |
| study and other studies have confirmed regional differences in STI prevalence, and the WHO study established that |
| PID risk is temporally related to IUD insertion procedures. Studies of the effectiveness of antibiotic prophylaxis to |
| prevent infectious complications are inconclusive due at least in part to use of sub-therapeutic regimens for |
| pathogens commonly implicated in PID. In summary, the IUD can be safe and effective if inserted under aseptic |
| conditions in women free of cervical infection. Further study is needed to define appropriate standards of care for IUD |
| insertion where STI prevalence is high and ability to rule out infection is limited. Even with safe insertion, IUD |
| promotion in areas of high STI/HIV prevalence must address women's needs for dual protection from infection and |
| unwanted pregnancy. (PubHealth.info Document ID: CONT1T 575-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Intrauterine contraceptive devices and risk of pelvic |
| inflammatory disease: standard of care in high STI prevalence settings.", is(are) Steen R; Shapiro K. The source of |
| this article is "Reproductive Health Matters. 2004 May;12(23):136-143.". This article was published in 2004 in |
| English language(s). (PubHealth.info® Document ID: CONT1T 575-06. All rights reserved with PubHealth.info) PIN: |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |